Well, the Royal College of Surgeons were at the meeting that I described with clinical leaders and actually the guidance that they've issued has been helpful in allowing some activity to continue in different parts of Wales, but it reflects the reality of where we are on the ground with, not just COVID, but with other harms that are coming in. Because I think part of this is, you're right about data and understanding what that data is, but it's also still then the judgments and the understanding of where people are on that waiting list. There'll be some people who are a higher clinical priority and it's the understanding of how that's taken through to deal with people to avoid the greatest amount of harm, and that will be different in different areas of the service. And, again, the Member will know that in some parts, delaying treatment can lead to irreversible harm, for example, on sight loss. In other areas, it can lead to discomfort and deterioration in that person's well-being, if you're waiting for a joint operation, for example. But that harm may be recovered. So, it's both understanding how to prioritise the waiting list and then to understand how you fairly judge the level of activity that each organisation is undertaking.

So, I'd be more than happy to continue the conversations that we already have with the Royal College of Surgeons on how we can be open and transparent about the levels of activity that are being restarted, but not to use as a simple, 'You're somewhere on a league table and you just have to get somewhere else', because, as I say, the pandemic isn't finished yet. When we move beyond the pandemic, then, yes, I think there'll be more and more data and more and more expectation in terms of my response to your first question: how have we managed to gear up different ways of working to deliver the required levels of activity whilst, of course, at the same time, taking care of our staff who will be exhausted when the pandemic is finally over?